Secrets of a covalent interaction for biomaterials and biotechnology: SpyTag and SpyCatcher  by Reddington, Samuel C & Howarth, Mark
Secrets of a covalent interaction for biomaterials and
biotechnology: SpyTag and SpyCatcher
Samuel C Reddington and Mark Howarth
Available online at www.sciencedirect.com
ScienceDirectSpyTag is a short peptide that forms an isopeptide bond
upon encountering its protein partner SpyCatcher. This
covalent peptide interaction is a simple and powerful tool for
bioconjugation and extending what protein architectures are
accessible. Here we review the origin and mechanism of
SpyTag/SpyCatcher, focusing on recent innovative
applications. Ligation of targeting-antibody with antigen
provided a simple route to vaccine generation. SpyRings,
from head-to-tail cyclisation, gave major enhancements  in
enzyme resilience. Linking multiple SpyCatchers gave
dendrimers for T-cell activation or Spy networks forming
hydrogels for stem cell culture. Synthetic biology
applications include integrating amyloid biomaterials with
living bacteria, for irreversible derivatisation of biofilms with
enzymes or nanoparticles. We also discuss further
opportunities to apply and enhance SpyTag/SpyCatcher
technology.
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Introduction
Modifying and assembling proteins is a key challenge for
our ability to explore and harness living systems. Biocon-
jugation allows us to study and manipulate the properties
of proteins, for example by allowing tracking [1], interac-
tion sensing [2] or conferring improved therapeutic prop-
erties [3]. Additionally, bioconjugation gives the ability to
create novel devices and biomaterials for anything from
energy harvesting [4] and medical diagnostics [5] to
cancer cell capture [6] or drug delivery [7]. Protein
bioconjugation initially exploited the chemistry of natural
amino acids, such as amino groups (Lys, N-terminus),
carboxyl groups (Asp, Glu, C-terminus) and sulfhydryl
groups (Cys). However, there is often poor control over
the site and number of modifications and incompatibilityCurrent Opinion in Chemical Biology 2015, 29:94–99 with complex mixtures or living systems. For many
devices or therapeutics, molecularly-defined conjugates
are highly desirable [8]. Therefore a range of more
selective non-covalent or bio-orthogonal covalent target-
ing approaches have been developed [9,10]. Non-natural
amino acids (nAAs) can introduce minimally obtrusive,
orthogonally reactive groups [1,11–13]. Rates vary
depending on the nAA (e.g. azido-containing, alkyne-
containing, norbornene-containing) from 104 M1 s1
to an impressive 104 M1 s1 for inverse-electron-de-
mand Diels–Alder cycloaddition [9,14–16]. A disadvan-
tage is the requirement for additional cellular machinery
for nAA incorporation (an engineered aminoacyl-tRNA-
synthetase/tRNA pair). Peptide tags (e.g. myc and FLAG
tags recognised by specific antibodies) are an alternative
strategy. However, the small interface between a peptide
and its cognate protein typically results in high off-rate
and minimal mechanical resilience. Therefore, protein
engineers have adapted natural proteins that form cova-
lent bonds to create ‘unbreakable’ peptide tags, including
split inteins [17], sortase [18], transglutaminase [19] and
the subject of this review, SpyTag/SpyCatcher.
Generating SpyTag/SpyCatcher
Pilins and adhesins of Gram-positive bacteria sometimes
contain spontaneous isopeptide bonds [20,21], often
within immunoglobulin-like domains CnaB1 or CnaB2
[22,23]. We generated SpyTag and SpyCatcher by split-
ting the CnaB2 domain from the fibronectin-binding
protein FbaB from Streptococcus pyogenes (Spy) [24,25].
CnaB2 was split into a 13 residue peptide (SpyTag) and
the 116 residue complementary domain (SpyCatcher)
(Figure 1a). These two parts spontaneously reconstitute
to form an isopeptide bond (Figure 1b) under a range of
temperatures (at least 4–37 8C), pH values (5–8), buffers
(no specific anion or cation required) and even with non-
ionic detergents [25]. Neither SpyTag nor SpyCatcher
contains cysteine residues. SpyTag and SpyCatcher
function well when fused at either the N-terminus or
C-terminus; there is not enough data yet to establish
the rules for their fusion within tight loops of folded
domains. SpyTag/SpyCatcher at 10 mM react to high
yield with a half-time of just over 1 minute (rate con-
stant = 1.4  103 M1 s1). Analogously, we were able to
split the major pilin Spy0128, yielding alternative reac-
tive pairs [26]. SpyTag/SpyCatcher has now been har-
nessed by a range of laboratories for bioconjugation
[27,28,29] and this review will provide an update of
novel directions, as summarised in Figure 1c.www.sciencedirect.com
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Generation, reaction and uses of SpyTag/SpyCatcher. (a) Cartoon of splitting CnaB2 into SpyCatcher (grey) and SpyTag (red). Residues forming
the isopeptide are shown as sticks (based on PDB 2X5P and 4MLI) [30]. (b) Environment of the isopeptide bond between Asp117 (carbons
orange) and Lys31 (carbons yellow), facilitated by Glu77 (carbons grey). (c) Discussed applications of SpyTag/SpyCatcher. (d) Reaction
mechanism. Lys31 nucleophilically attacks Asp117, followed by proton transfers involving Glu77, leading to a neutral tetrahedral intermediate and
then release of water and formation of the amide bond.SpyTag/SpyCatcher reaction mechanism
The reaction mechanism of the intact CnaB2 domain
(and presumably SpyTag/SpyCatcher) has been inves-
tigated by crystallography, NMR and quantum me-
chanics/molecular mechanics (QM/MM) [31,32]. The
protein environment is vital for bringing the residues
into optimal proximity and orientation. Also the hydro-
phobic surroundings alter the pKa of the side-chains,
favouring the more reactive neutral protonation states.
Prior to reaction, the carboxyl groups of Glu77 and
Asp117 are thought to form a double hydrogen-bond,
facilitating reaction of Asp117 (Figure 1d). Ne of Lys31
nucleophilically attacks the Cg of Asp117, forming a
zwitterionic intermediate (Figure 1d). There are then
two concerted proton transfers, with the proximal
Glu77 acting as a proton shuttle. A neutral tetrahedral
intermediate forms, which then collapses with release
of a water molecule (Figure 1d). H2O release andwww.sciencedirect.com formation of the amide bond is rate-limiting, with
an energy barrier of 102 kJ/mol for the intact CnaB2
[31].
New uses of SpyTag/SpyCatcher for
biotechnology
One area of promise is stabilising enzymes. Fusing Spy-
Tag and SpyCatcher to the termini of a protein of interest
leads to spontaneous cyclisation (Figure 2a). Our group
employed this approach to generate cyclised b-lactamase
and dihydrofolate reductase (DHFR) [33]. SpyRing b-
lactamase was resilient to aggregation up to 100 8C
(Figure 2b) whereas the wild-type enzyme irreversibly
aggregated over 37 8C. Following heating to 100 8C and
re-testing at room temperature, the SpyRing enzyme
retained most of its initial activity (Figure 2c), a greater
impact on enzyme resilience than other cyclisation chem-
istries [33].Current Opinion in Chemical Biology 2015, 29:94–99
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Applications of one-to-one SpyTag/SpyCatcher locking. (a) SpyRing generation: the protein of interest is genetically fused with an N-terminal
SpyTag and C-terminal SpyCatcher (red), which spontaneously lock together. (b) SpyRing resilience to aggregation. Cyclised (red) or wild type
(blue) b-lactamase were heated to the indicated temperature, centrifuged and soluble protein recovered (mean  1 s.d., n = 3). (c) Preservation of
enzyme activity of cyclised (red) compared to wild type b-lactamase (blue) at room temperature, following heating to 100 8C for 10 minutes
(mean  1 s.d., n = 3). (d) Modular vaccine production. A suitable immunoregulatory molecule, scFv-Fc (yellow) is fused with SpyTag and
covalently reacts with SpyCatcher-antigen. (e) Production of synthetic vaccines by modular combination of function (Func) units with antigens.
Classic genetic fusion requires cloning and expressing m  n possibilities; SpyTag/SpyCatcher conjugation only requires m + n expressions.SpyTag/SpyCatcher was recently established for vaccine
optimisation [34]. An antigen is covalently linked to an
immunoregulatory ‘function’ unit, such as an antibody
targeting to the optimal location (e.g. dendritic cells, the
most efficient antigen-presenting cell-type). SpyTag was
fused to a single-chain Fv-Fc specific for the dendritic
cell-surface marker DEC205 (Figure 2d). SpyCatcher was
fused to the model ovalbumin antigen or a tick-borne
encephalitis virus domain and then conjugated to anti-
DEC205-SpyTag to create a full vaccine. The modular
vaccine generated efficient cytotoxic T-cell and antibody
responses [34] and may overcome the frequent time-
consuming challenges in finding expression hosts and
folding conditions compatible with both the targeting
unit and the antigen. The modular strategy also vastly
reduces the number of constructs that need to be cloned
and purified (Figure 2e).
Creation of new protein architectures and
biomaterials using SpyTag/SpyCatcher
One current limit in the ability to engineer proteins is the
construction of large, multi-component architectures in aCurrent Opinion in Chemical Biology 2015, 29:94–99 defined manner. The specific and covalent SpyTag/Spy-
Catcher interaction provides a powerful way to build and
link proteins into such assemblies [28]. One simple
solution for higher-order assembly is to bring together
SpyTag/SpyCatcher with one of the most widely used
non-covalent assembly tools: streptavidin/biotin. We
combined traptavidin (a streptavidin mutant with 10-fold
decreased off-rate for biotin) with SpyTag/SpyCatcher,
creating SpyAvidin nanohubs (Figure 3a) [35]. Here,
dead streptavidin subunits that are incapable of binding
biotin are fused to SpyTag or SpyCatcher. Denatured
subunits were mixed with traptavidin subunits; refolding
and ion-exchange chromatography generated defined
hetero-tetramers containing 1 to 4 SpyTags or SpyCatch-
ers. When combined, tetramers spontaneously reacted
to form specific assemblies with different biotin-
binding capacities. Tetramers with 0–3 biotin-binding
sites, octamers with up to 6 biotin-binding sites and even
eicosamers with 12 biotin-binding sites were created
(Figure 3a). The importance of these defined assemblies
was shown by attaching biotinylated peptide-MHC class I
complexes, an activator of T-cell signalling. The responsewww.sciencedirect.com
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Creation of new protein architectures and protein-based materials using SpyTag/SpyCatcher. (a) SpyAvidin hubs for multimerisation, by integrating
streptavidin/biotin with SpyTag/SpyCatcher. The eicosamer (20 streptavidin-based subunits) binds 12 biotin-containing ligands. (b) Stimulation of
T-cell line using SpyAvidins with different numbers of peptide-MHC class I; Eicosamer = 12; Octamer = 6; Tetramer = 4 (proportion of cells above
threshold marked). (c) Hydrogels for cell growth. ELPs fused with multiple SpyCatchers and SpyTags spontaneously form Spy networks. (d)
Maintenance of pluripotency in a Spy network. Embryonic stem cells in a Spy network with (top row) or without (bottom row) SpyTag-leukaemia
inhibitory factor-SpyTag were stained in green for the pluripotency marker Oct4. DAPI marks nuclei in blue and phalloidin marks filamentous actin
in red. Reproduced with permission [37]. (e) Catalytic biofilms. E. coli secreting SpyTag-fused CsgA make curli, decorated with SpyCatcher
fused to the enzyme of interest and conferring increased stability to the enzymes.of T-cells increased with increasingly multivalent stimu-
lation (Figure 3b) [35]. Given the huge range of bioti-
nylated ligands commercially available, SpyAvidins
should be a plug-and-play route to a range of stable
defined assemblies.
Zhang and colleagues also built unfamiliar protein
architectures, using SpyTag-fused and SpyCatcher-fusedwww.sciencedirect.com elastin-like polypeptides (ELPs) [36]. A small number of
components generated architectures of diverse shapes,
including star and H-shaped. Sun et al. expanded this
strategy to synthesise hydrogels [37]. Mixing ELP
fusions of two terminal SpyCatchers with terminally
and internally fused SpyTags, robust protein matrices
termed Spy networks form spontaneously (Figure 3c).
Spy networks were customised by introducing a protein ofCurrent Opinion in Chemical Biology 2015, 29:94–99
98 Mechanistic biologyinterest internally: a Spy network containing leukaemia
inhibitory factor (LIF) encapsulated and maintained the
pluripotency of embryonic stem cells (Figure 3d) [37].
Living systems often depend upon dynamic reversible
interactions, but real-world applications of synthetic bi-
ology may require integration of living systems with
irreversible assemblies, hence the interest in living mate-
rials. SpyTag/SpyCatcher has been applied to construct
catalytic biofilms, which hold promise for complex indus-
trial transformations. The self-assembling fibril subunit
CsgA was fused to SpyTag and secreted from Escherichia
coli [27,38]. The biofilm bearing the tagged curli fila-
ments could then be functionalised with an enzyme (or
multiple enzymes in a reaction pathway) site-specifically
tagged to SpyCatcher to create a catalytic biofilm
(Figure 3e). Incorporation of amylase into such biofilms
increased resilience to harsh pH and solvents and could
improve long-term stability [38].
Future challenges
SpyTag/SpyCatcher has shown a range of intriguing
applications, but every nascent technology requires opti-
misation. In our hands, fusion to SpyTag rarely disturbs
function or yield. However, SpyCatcher is a larger fusion,
even after we reduced the size from 116 to 84 residues
[30]. SpyCatcher is also a split protein (and may have
dynamic tertiary structure), so even though SpyCatcher is
a satisfactory fusion tag in different proteins using bacte-
rial and mammalian expression, there can still be a
reduction in expression yield or surface display efficiency.
One route we explored was to split SpyTag/SpyCatcher
further into three parts: two peptide tags (SpyTag and
KTag) and the third part, SpyLigase, to direct linkage of
the two peptides. SpyLigase generated affibody polymers
to enhance the sensitivity of magnetic cancer cell capture
[39]. The reaction rate of SpyTag/SpyCatcher is usually
effective for in vitro ligation, but cellular proteins of
interest may be at subnanomolar concentrations and so
the required reaction times may be slower than cellular
events. Therefore, work is ongoing to advance Spy-
Catcher towards an ideal fusion tag and the SpyTag/
SpyCatcher reaction rate towards the diffusion limit.
Conclusions
SpyTag/SpyCatcher has now established itself as a simple
route to covalent protein conjugation and is quickly
finding application by a range of laboratories. This review
has highlighted some exciting uses of SpyTag/Spy-
Catcher in biotechnology and synthetic biology. Many
of the examples given are proofs-of-principle, so it will be
exciting to see how the techniques will mature. For
example, it will be important to see how far SpyTag/
SpyCatcher cyclisation may be generalised for enhancing
resilience, to facilitate molecular evolution and industrial
enzyme application. Also, customisable hydrogels may be
extended to regenerative medicine, transplantation andCurrent Opinion in Chemical Biology 2015, 29:94–99 tissue engineering. Although precise nanoscale assembly
can now be achieved with DNA, programmed nano-
assembly with proteins is still in its infancy, but such
initial applications suggest that protein nano-assembly
will contribute to addressing major biological challenges.
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